Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 27 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-12 Glover Stephen C. Director Grant or award · Employee Stock Option (Right to Buy) +54,876 54,876
2025-06-11 Glover Stephen C. Director Grant or award · Employee Stock Option (Right to Buy) +22,700 22,700
2025-02-28 Glover Stephen C. Director Purchase +15,061 $1.66 $25K 78,851
2025-02-28 Glover Stephen C. Director Purchase · Common Warrant +15,061 15,061
2024-06-24 Glover Stephen C. Director Grant or award · Employee Stock Option (Right to Buy) +9,000 9,000
2023-07-14 Glover Stephen C. Director Grant or award · Employee Stock Option (Right to Buy) +9,000 9,000

Page 1 of 1 · 6 trades